Fibroblast growth factor 21 (FGF21) is a hepatokine that acts as a global starvation signal to modulate fuel partitioning and metabolism and repress growth 1 ; however, the site of action of these diverse effects remains unclear. FGF21 signals through a heteromeric cell-surface receptor composed of one of three FGF receptors (FGFR1c, FGFR2c or FGFR3c) in complex with b-Klotho 2-4 , a single-pass transmembrane protein that is enriched in metabolic tissues 5 . Here we show that in addition to its known effects on peripheral metabolism, FGF21 increases systemic glucocorticoid levels, suppresses physical activity and alters circadian behavior, which are all features of the adaptive starvation response. These effects are mediated through b-Klotho expression in the suprachiasmatic nucleus of the hypothalamus and the dorsal vagal complex of the hindbrain. Mice lacking the gene encoding b-Klotho (Klb) in these regions are refractory to these effects, as well as those on metabolism, insulin and growth. These findings demonstrate a crucial role for the nervous system in mediating the diverse physiologic and pharmacologic actions of FGF21.
Previous studies have shown that FGF21 can cross the blood-brain barrier 6 , is detectable in human cerebrospinal fluid 7 and modulates phosphorylation cascades and gene expression in whole hypothalami 8, 9 . Intracerebroventricular injection of FGF21 into rats increases the metabolic rate and insulin sensitivity 10 , although the site of action is unknown. To determine how and where FGF21 may be acting centrally, we first determined the expression of Klb in the nervous system using anatomically guided laser-capture microdissection (LCM) of specific hypothalamic and brainstem nuclei and of specific sensory ganglia from parasympathetic and sympathetic divisions of the peripheral nervous system. Quantitative PCR (qPCR) showed that Klb is selectively expressed in the hypothalamus in the suprachiasmatic nucleus (SCN; Fig. 1a) , the site of a circadian pacemaker that orchestrates entrainment of animals to their external environment and gates the timing of diverse behavioral, physiological and hormonal rhythms [11] [12] [13] [14] . We found that Klb is also expressed in the hindbrain in key sets of neurons of the dorsal vagal complex (DVC), including the area postrema and the nucleus tractus solitarii (NTS), and in the nodose ganglia, where vagal nerve sensory neurons reside (Fig. 1a) . The components of the vagus nerve and its targets in the brainstem comprise a sensory unit that receives and integrates information from the viscera regarding metabolic and physiologic status 15 . The localization of Klb in the SCN and DVC was confirmed by in situ hybridization ( Fig. 1b and Supplementary Fig. 1) . In contrast to Klb, Fgfr1c, Fgfr2c and Fgfr3c are broadly expressed in the nervous system ( Fig. 1a) . Fgf21 mRNA is undetectable in any of these regions (data not shown).
Given that Klb localized to the SCN, we evaluated the circadian effect of long-term FGF21 exposure on gene expression and metabolic parameters using Fgf21 transgenic (Tg(Fgf21)) mice, in which an Fgf21 transgene is under the control of the liver-selective apolipoprotein E promoter 16 . Plasma FGF21 concentrations varied between 1,000 and 2,000 ng ml −1 in Tg(Fgf21) mice ( Supplementary Fig. 2a ). In the hypothalamus, the circadian pattern of Klb expression was unchanged in Tg(Fgf21) mice compared to wild-type littermates ( Supplementary Fig. 2b ). There also was no difference in the expression of Fgfr1c or the circadian genes Bmal1, Clock and Per2 in the hypothalamus of Tg(Fgf21) mice ( Supplementary Fig. 2b ). In liver, Klb expression was consistently higher in the Tg(Fgf21) compared to wild-type littermate mice ( Supplementary Fig. 2c ). There were modest differences between Tg(Fgf21) and wild-type littermates in the expression of Bmal1, Clock and Per2 in liver, which were probably a consequence of differences in SCN output and corticosterone concentrations (see below). Liver expression of insulin-like growth factor binding protein-1 (Igfbp1), cytochrome P450 (Cyp2d9) and hydroxysteroid dehydrogenase (Hsd3b5), which are regulated by growth hormone, was reciprocally regulated in Tg(Fgf21) mice throughout the cycle (Supplementary Fig. 2c ). Plasma insulin, glucose, triglyceride and cholesterol concentrations were consistently lower in Tg(Fgf21) mice throughout the light cycle ( Supplementary Fig. 2a ).
FGF21 regulates metabolism and circadian behavior by acting on the nervous system Taken together, these data indicate that FGF21 does not affect central clock genes but might affect SCN output.
To test directly whether the SCN is a target of FGF21 action, we deleted the Klb gene from the SCN by crossing loxP-flanked Klb fl/fl (Klb tm1 ) mice 17 with a calcium/calmodulin-dependent protein kinase II α (Camk2a)-Cre line, in which Cre recombinase is expressed widely in the forebrain and hindbrain 18 . In the resulting Klb tm1(Camk2a) mice, Klb mRNA expression was reduced in both the SCN and DVC to 15% of wild-type expression by 6 months of age ( Fig. 1c) . Klb expression was unaffected in liver and adipose tissue ( Supplementary Fig. 3a ).
To control for deletion of Klb in the DVC, we crossed Klb tm1 mice with a Phox2b-Cre line in which Cre is expressed in the hindbrain 19 , including neurons in the dorsal motor nucleus of the vagus, NTS, area postrema and nodose ganglia. In the resulting Klb tm1(Phox2b) mice, Klb expression was lower in the DVC, but not in the SCN, liver or adipose tissues, compared to Klb tm1 controls ( Fig. 1c and Supplementary Fig. 3b ).
To study the effects of FGF21 on the nervous system, we bred Klb tm1(Camk2a) or Klb tm1(Phox2b) mice to the Tg(Fgf21) mice to produce Klb tm1(Camk2a) ; Tg(Fgf21) and Klb tm1(Phox2b) ; Tg(Fgf21) mice, respectively. Plasma FGF21 concentrations were elevated to similar levels in all Tg(Fgf21) mouse lines (Supplementary Table 1 ). Given that the primary function of the SCN is to drive circadian behavior and to entrain these rhythms to light cycles, we measured the effect of FGF21 overexpression on daily wheel-running behavior under various lighting conditions. Representative actograms for wild-type and Tg(Fgf21) mice are shown in Figure 2a ,b and Supplementary Figure 4a . Tg(Fgf21) mice showed significantly lower total wheel-running activity compared to wild-type littermates (Fig. 2c,d and Supplementary  Table 2 ), resulting in lower amplitude rhythms as assessed by fast Fourier transform analysis ( Supplementary Table 2 ). Additionally, the Tg(Fgf21) mice did not consolidate their running to the dark phase ( Fig. 2c,d and Supplementary Table 2 ). Overall, activity remained nocturnal in both wild-type and Tg(Fgf21) mice ( Fig. 2c and Supplementary Table 2 ), demonstrating that entrainment to light was intact, although the phase angle of entrainment was advanced for the Tg(Fgf21) mice. To determine whether the pace of the circadian clock was affected, we measured the free-running period length of the activity rhythm in constant darkness. The circadian period for all mice was identical (23.5 ± 0.1 h, Supplementary Table 2 ), which indicates that the behavioral alterations seen in the Tg(Fgf21) mice were probably caused by an inhibition of clock output rather than an effect on the molecular clock per se.
To assess whether the behavioral alterations observed for Tg(Fgf21) mice were mediated by the SCN, we evaluated Klb tm1 ; Tg(Fgf21) and Klb tm1(Camk2a) ; Tg(Fgf21) mice on running wheels. Compared to wildtype littermates and similarly to Tg(Fgf21) mice, Klb tm1 ; Tg(Fgf21) mice showed lower overall activity, reduced robustness of rhythm and higher amounts of running during the light phase ( Fig. 2e-h , Supplementary Fig. 4b and Supplementary Table 2 ). Deletion of β-Klotho in the nervous system normalized these parameters ( Fig. 2f-h, Supplementary Fig. 4b and Supplementary Table 2 ), demonstrating the importance of the SCN in mediating these behaviors in response to chronically elevated FGF21. These data provide further evidence that elevated FGF21 relaxes the inhibitory function of the SCN on activity during the light phase.
To test whether endogenous FGF21 regulates circadian behaviors, we performed wheel-running experiments with Fgf21 −/− and wildtype mice from matched backgrounds fed a ketogenic diet. Although it was not technically possible to administer FGF21 to mice while they were in the wheel-running experiments, the ketogenic diet offered an alternative method by mimicking the starvation response and increasing Fgf21 mRNA in the liver and FGF21 concentrations in the blood to near fasting levels 20 (Supplementary Fig. 5a ). In our experiments, the ketogenic diet increased plasma FGF21 concentrations to 10-30 ng ml −1 npg in wild-type mice ( Supplementary Fig. 5a and Supplementary Table 3 ). When challenged with the ketogenic diet, wild-type mice showed reduced overall activity but increased activity during the light phase ( Fig. 3a-c , Supplementary Fig. 5b and Supplementary  Table 3 ), similar to that seen in Tg(Fgf21) mice ( Fig. 2c) . Chow-fed Fgf21 −/− mice behaved like their wild-type counterparts (Fig. 3d) . Whereas total activity was similarly lower in Fgf21 −/− and wild-type mice from matched backgrounds in response to the ketogenic diet compared to chow diet ( Fig. 3e-g and Supplementary Table 3 ), the diet-induced increase in light-phase activity was significantly higher in Fgf21 −/− mice compared to wild-type mice from matched backgrounds ( Fig. 3h , Supplementary Table 3 and Supplementary  Fig. 5b ). Thus, physiologic levels of FGF21 can modulate circadian behavior.
Given that glucocorticoids play a crucial part in the starvation response and are regulated by both the SCN and hindbrain 22, 23 , we examined glucocorticoid homeostasis in Tg(Fgf21) mice. Consistent with the lower SCN clock output of Tg(Fgf21) mice, arginine vasopressin (Avp) expression was lower and corticotropin-releasing hormone (Crh) expression was higher in hypothalamus of Tg(Fgf21) mice compared to wild-type littermates (Supplementary Fig. 2b) . These changes were accompanied by higher concentrations of plasma corticosterone and lower concentrations of adrenocorticotropic hormone (ACTH) (Supplementary Fig. 2a ). In Klb tm1 ; Tg(Fgf21) mice, plasma corticosterone was approximately four-fold higher compared to control Klb tm1 mice, and this effect was lost in Klb tm1(Camk2a) ; Tg(Fgf21) mice (Fig. 4b) . Although there was a wide variation in plasma ACTH concentrations, we observed a reciprocal relationship We next evaluated the effect of eliminating β-Klotho from the nervous system on metabolic parameters. Neither the Klb tm1(Camk2a) nor the Klb tm1(Phox2b) mice had changes in body weight or other metabolic parameters under ad libitum chow-fed conditions ( Fig. 4a  and Supplementary Table 1 ). As expected 16, 21 , Klb tm1 ; Tg(Fgf21) mice had significantly lower body weight, shorter tibia length and lower plasma insulin and cholesterol concentrations than control Klb tm1 mice, but no change in percentages of lean mass or fat mass ( Fig. 4a, Supplementary Fig. 6a and Supplementary Table 1) . Notably, the changes in body weight, tibia length and plasma insulin and cholesterol concentrations observed in Klb tm1 ; Tg(Fgf21) mice were reversed in Klb tm1(Camk2a) ; Tg(Fgf21) mice ( Fig. 4a,  Supplementary Fig. 6a and Supplementary Table 1) . These changes were not reversed in Klb tm1(Phox2b) ; Tg(Fgf21) mice, with the exception of cholesterol concentrations ( Fig.4a and Supplementary  Table 1 ). These data indicate that FGF21 action on the SCN mediates the effects of FGF21 on body weight and insulin levels.
npg between ACTH and glucocorticoids ( Fig. 4b) , indicating that feedback regulation at the level of the pituitary was intact in the Klb tm1 ; Tg(Fgf21) mice. We observed a similar pattern of corticosterone and ACTH regulation experiments performed with Klb tm1(Phox2b) and Klb tm1(Phox2b) ; Tg(Fgf21) mice, although the plasma corticosterone in Klb tm1 ; Tg(Fgf21) mice did not reach significantly higher concentrations relative to Klb tm1 control mice in these experiments (Fig. 4b) . Together, these data indicate that levels of FGF21 were delivered by minipump for 7 d to Klb tm1 and Klb tm1(Camk2a) mice. Under these conditions, steady-state plasma FGF21 concentrations were ~9 ng ml −1 (Fig. 4e) , which is comparable to peak levels obtained during starvation 19 (Supplementary  Fig. 6c ) and lower than those obtained by ketogenic diet feeding 20 (Supplementary Fig. 5a ). There was no effect of FGF21 administration on body weight (Fig. 4f) . In agreement with the Tg(Fgf21) mouse studies, FGF21 reduced basal plasma insulin concentrations in Klb tm1 but not Klb tm1(Camk2a) mice (Fig. 4f) . Notably, FGF21 significantly increased plasma corticosterone concentrations in Klb tm1 but not Klb tm1(Camk2a) mice (Fig. 4g) . In gene expression studies, FGF21 increased Igfbp1 and Pck1 expression and decreased Cyp2d9 and Hsd3b5 expression in livers of Klb tm1 but not Klb tm1(Camk2a) mice (Fig. 4h,i) . These data recapitulate those seen in the Tg(Fgf21) mouse studies and demonstrate that physiologic concentrations of FGF21 act on the nervous system to regulate metabolism. 
FGF21 acts on both the SCN and hindbrain regions of the nervous system to increase corticosterone levels.
We next assessed the consequences of eliminating β-Klotho from the SCN on FGF21-regulated gene expression in liver and adipose tissue. In liver, Klb tm1 ; Tg(Fgf21) mice had higher Igfbp1 mRNA levels and lower Cyp2d9 and Hsd3b5 mRNA levels compared to Klb tm1 control mice (Fig. 4c) . The effect of the Fgf21 transgene on the expression of these genes was lost in Klb tm1(Camk2a) ; Tg(Fgf21) mice but not in Klb tm1(Phox2b) ; Tg(Fgf21) mice (Fig. 4c) , which is consistent with FGF21 acting on the SCN to regulate growth. Hepatic expression of the gene encoding the gluconeogenic protein phosphoenolpyruvate carboxykinase (Pck1), which is induced by glucocorticoids, was higher in Klb tm1 ; Tg(Fgf21) mice compared to Klb tm1 littermate control mice (Fig. 4d) . Consistent with the FGF21-dependent central nervous system effects on plasma corticosterone, Pck1 expression was unchanged in Klb tm1(Camk2a) ; Tg(Fgf21) mice and lower in Klb tm1(Phox2b) ; Tg(Fgf21) mice compared to Klb tm1 littermate control mice (Fig. 4d) . In adipose tissue, adipose triglyceride lipase (Atgl), stearoyl-CoA desaturase 1 (Scd1) and hydroxysteroid dehydrogenase 11b1 (Hsd11b1) expression was higher in Klb tm1 ; Tg(Fgf21) mice compared to that in Klb tm1 control mice (Supplementary Fig. 6b) . The FGF21-dependent expression of these genes was unaffected in both the Klb tm1(Camk2a) ; Tg(Fgf21) and Klb tm1(Phox2b) ; Tg(Fgf21) mice (Supplementary Fig. 6b) , which is consistent with the notion that FGF21 acts directly on white adipose tissue to regulate their expression 17 .
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In summary, we show that FGF21 acts directly through its coreceptor β-Klotho in the brain to lower insulin, inhibit growth and alter light-dark cycle activity, all of which occur during starvation 24, 25 . Coincident with this role, we show that FGF21 acts on the nervous system, both at the level of the hypothalamus and the hindbrain, to increase systemic corticosterone levels, another prominent feature of starvation. This finding may explain the liver-nonautonomous inductive effect of FGF21 on hepatic gluconeogenesis 26 . In an accompanying paper 27 we show that FGF21 also acts as a starvation signal to inhibit female fertility. These effects on circadian behavior, glucocorticoids, metabolism and reproduction are consistent with our results showing that FGF21 suppresses the expression of the neuropeptide vasopressin in the SCN (Supplementary Fig. 2b and ref. 27 ). The finding that diverse effects of FGF21 are mediated by suppressing the output of the SCN (and by acting on the DVC) reveals a previously unrecognized regulatory circuit between the liver and brain. Although not typically regarded as being influenced by diet, the SCN expresses receptors for other metabolic factors, including leptin and ghrelin 28, 29 . Thus, the SCN seems to have a broad role in gating adaptive responses to nutritional status. In this respect, we note that signaling through the SCN also is required for the pharmacologic effects of FGF21 on lowering cholesterol. Thus, it will be of interest to determine what other positive effects of FGF21, when used as an antiobesity drug, may involve the nervous system. Finally, the observation that FGF21 is elevated in conditions related to the metabolic syndrome 30 , in addition to during starvation, raises the possibility that FGF21 working through the nervous system may play a part in mediating some of the established effects of the metabolic syndrome on altered circadian and metabolic parameters.
MeTHodS
Methods and any associated references are available in the online version of the paper. 
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Reprints and permissions information is available online at http://www.nature.com/ reprints/index.html. Mice. All procedures and use of mice were approved by the Institutional Animal Care and Use Committee of University of Texas (UT) Southwestern Medical Center Dallas. Unless otherwise stated in specific dietary studies, all mice were maintained on 2916 Global Diet (Harlan Teklad). Ketogenic diet was from BioServ F3666. Male mice were used in all studies. C57BL/6J mice used for laser-capture microdissection (LCM) and in situ hybridization were obtained from Jackson or from the UT Southwestern mouse breeding core, which sources its colony breeders from Jackson. The C57BL/6J Tg(Fgf21), C57BL/6J Fgf21 −/− , C57BL/6J; 129/Sv Klb tm1 and C57BL/6J Camk2a-Cre lines have been previously described [16] [17] [18] 26 . The C57BL/6J Phox2b-Cre line 4 expresses Cre recombinase in the hindbrain to a greater extent than line 3, in addition to some hypothalamic (excluding the suprachiasmatic nucleus (SCN)) and cortical sites 19 . Mice were killed by rapid decapitation to avoid stress responses. Trunk blood was collected into K + EDTA tubes, and plasma was separated and stored at −80 °C until assayed. Tissues were collected, snapfrozen in liquid nitrogen and stored at −80 °C until assayed. For minipump experiments, pumps (ALZET Micro-Osmotic Pump Model 1007D) were filled with vehicle (25 mM HEPES, 150 mM NaCl, 50% glycerol) or recombinant human fibroblast growth factor 21 (FGF21) (to deliver 1.1 µg in 0.5 µl per hour) and implanted subcutaneously under isoflurane inhalation anesthesia. Mice were decapitated at zeitgeber time (ZT) 3, 7 d after implantation.
Neuroanatomical mapping, LCM and peripheral ganglia. At the start of the light cycle, C57BL/6J males were deeply anesthetized with chloral hydrate and decapitated. Left nodose ganglion and midthoracic dorsal root ganglia were rapidly collected and frozen in liquid nitrogen. Brains were dissected, slow-frozen on dry ice and stored at −80 °C until sectioning. Brains were cryosectioned at 30 µm and thaw-mounted onto silane-coated polyethylene-naphthalate (PEN) membrane glass slides (Molecular Devices, Sunnyvale, CA) and stored at −80 °C. Slides were lightly fixed in 75% ethanol immediately before thionin staining. Slides were then dehydrated in a graded ethanol series followed by 5 min in xylenes. The Arcturus Veritas Microdissection System (Molecular Devices) was used to isolate each nucleus based on defined neuroanatomical boundaries 31 , as described previously 32 . Nuclei collected are listed in Supplementary Table 4 . Peripheral ganglia RNA were isolated using Ambion's Ribopure Kit, and LCM nuclei RNA was extracted using the PicoPure RNA Isolation Kit (Molecular Devices) with on-column DNase I treatment (Qiagen, Valencia, CA) and stored at −80 °C. RNA quality was assessed using the Experion Automated Electrophoresis system (Bio-Rad, Hercules, CA).
cDNA was synthesized using the High-Capacity cDNA Kit (Applied Biosystems), followed by cDNA preamplification of specific gene targets using TaqMan Preamplification Buffer (Applied Biosystems) according to the manufacturer's directions. Owing to sufficiently high expression, it was not necessary to preamplify 18S rRNA, which was used as the normalizer gene. All gene expression levels were measured with an Applied Biosystems 7900HT Sequence Detection System using the efficiency-corrected ∆C t method as previously described 33, 34 . The anatomic specificity of the LCM dissections was confirmed by qPCR for the expression of known marker genes in each nucleus.
In situ hybridization. C57BL/6J males were deeply anesthetized with chloral hydrate and transcardially perfused with saline, followed by formalin. Brains were dissected and post-fixed in formalin for several hours before overnight incubation in 20% sucrose. Brains were cut at 25 µm, 1:4 series using a sliding microtome, and sections were stored in cryoprotectant at −20 °C until use. Free-floating in situ hybridization was carried out as described 29 using a 33 P-labeled antisense probe for Klb cDNA (spanning base pairs 169-692). Sections were mounted onto SuperFrost plus slides, rostral to caudal, and exposed to film for approximately 4 d. Developed film was scanned using an Epson ImageScanner III.
qPCR. Total RNA from liver, white adipose and brown adipose tissue was isolated using RNA Stat60 (Teltest), and cDNA was synthesized using the High Capacity cDNA Kit (Applied Biosystems). Gene expression profiles of peripheral tissues were performed using the ∆∆C T assay as described 33 .
Blood analyses. Glucose, ketones, cholesterol and triglycerides were measured by colorimetric assays (Wako, Pointe Scientific), corticosterone and ACTH were measured by radioimmunoassay (MP Biomedical) and insulin and mouse or human FGF21 were measured by ELISA (Crystal Chem, Biovendor), according to manufacturers' instructions 17, 26, 34 .
Wheel running. Wheel-running experiments were performed as described 35 . Singly housed mice were entrained to a 12 h light, 12 h dark cycle (LD12:12) for 18 d, followed by 21 d of constant darkness (DD) before return to LD12:12 for 15 d. Data were analyzed using ClockLab 36 . Measurements of total daily activity, including percentages of light and dark counts, were taken from day 6 to day 15 of LD recording. Period and amplitude were calculated from day 29 to day 38 during DD. Phase was determined using activity onsets from day 22 to day 28 with extrapolation to the first day of DD (day 19).
Statistical analyses. Data are expressed as mean ± s.e.m. GraphPad Prism was used for analysis of variance with Bonferroni's post hoc test or two-tailed Student's t-test. P < 0.05 was considered significant.
